Opportunity Information: Apply for CDC RFA DP10 1011
Apply for CDC RFA DP10 1011
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "State Approaches to Estimating Incidence and Prevalence of Lupus" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Apr 1, 2010 and posted on Apr 1, 2010.
- Applicants must submit their applications by May 10, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $3,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,500,000.00 in funding.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible applicants that can apply for this funding opportunity are listed below State and local governments health departments with a population of 1 million or more or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau). A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The CDC funding opportunity titled "State Approaches to Estimating Incidence and Prevalence of Lupus" (Funding Opportunity Number CDC RFA DP10-1011) is a discretionary cooperative agreement designed to strengthen public health knowledge about lupus by producing more credible, population-based estimates of how often lupus occurs (incidence) and how many people are living with it (prevalence). The central public health problem this program targets is that lupus is relatively uncommon but can be highly disabling and costly, and existing estimates are often uncertain, inconsistent across regions, or based on incomplete case finding. This announcement specifically emphasizes improving estimates among Hispanic and Asian populations, groups for whom data have historically been more limited and where patterns of disease burden may differ.
The work is positioned as a continuation of the National Arthritis Action Plan: A Public Health Strategy (NAAP). In practical terms, that means the program is meant to build the evidence base needed for better planning, awareness, and public health response to arthritis and related rheumatic diseases. The announcement calls for the implementation and completion of two additional population-based lupus studies, focusing on both systemic lupus erythematosus (SLE) and skin lupus (often referred to as cutaneous lupus). By specifying population-based studies, the CDC is signaling that the expectation is to capture cases across a defined population (not just within a single clinic or health system), which is key for producing credible incidence and prevalence measures.
The CDC planned to make two awards under this opportunity, with an estimated total funding amount of $3,000,000. The award ceiling is listed as $1,500,000, which aligns with the expectation that two awards could be funded at up to that amount each. There is no cost sharing or matching requirement, lowering barriers for eligible public agencies to apply. The funding instrument is a cooperative agreement, which generally implies substantial involvement by the CDC during the project period, such as technical assistance, guidance on methodology, and coordination to support consistency and comparability across study sites.
Eligibility is focused on governmental public health capacity at scale. Applicants may include state and local government health departments serving populations of 1 million or more, as well as their bona fide agents. The eligibility language explicitly includes U.S. territories and affiliated jurisdictions, including the District of Columbia, Puerto Rico, the U.S. Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau. If an entity applies as a bona fide agent rather than the government health department itself, it must provide a letter from the relevant state or local government documenting that status, which is an important administrative requirement.
Administratively, the opportunity was posted on April 1, 2010, with an application deadline of May 10, 2010, and it was later archived on June 9, 2010. The CFDA number associated with the program is 93.283, under the Centers for Disease Control and Prevention category of investigations and technical assistance, reflecting the surveillance and epidemiologic research nature of the work rather than direct clinical service delivery.
For applicants or interested parties needing help accessing the full announcement, the listed point of contact is the CDC Procurement and Grants Office, reachable by phone at 770-488-2700 or by email at pgotim@cdc.gov.
Frequently Asked Questions (FAQs): State Approaches to Estimating Incidence and Prevalence of Lupus (CDC RFA DP10-1011)
What is this CDC funding opportunity?
This opportunity is titled "State Approaches to Estimating Incidence and Prevalence of Lupus" (Funding Opportunity Number CDC RFA DP10-1011). It is a discretionary cooperative agreement intended to strengthen public health knowledge about lupus by producing more credible, population-based estimates of lupus incidence (how often new cases occur) and prevalence (how many people are living with lupus).
What public health problem is the program trying to address?
The program targets the problem that lupus is relatively uncommon but can be highly disabling and costly, and current estimates are often uncertain, inconsistent across regions, or based on incomplete case finding. The goal is to improve the credibility and comparability of population-based estimates.
What conditions are included in the studies?
The announcement calls for studies covering both systemic lupus erythematosus (SLE) and skin lupus (often referred to as cutaneous lupus).
What does "incidence" mean in the context of this opportunity?
Incidence refers to how often lupus occurs, meaning the number of new cases identified within a defined population over a specified period of time.
What does "prevalence" mean in the context of this opportunity?
Prevalence refers to how many people are living with lupus in a defined population during a specified time period.
What does the CDC mean by "population-based" studies?
The announcement emphasizes population-based lupus studies, meaning the expectation is to capture cases across a defined population rather than limiting findings to a single clinic or health system. This approach supports more credible incidence and prevalence estimates.
Why does the opportunity emphasize Hispanic and Asian populations?
The announcement specifically highlights improving estimates among Hispanic and Asian populations because data for these groups have historically been more limited, and disease burden patterns may differ.
How many awards did the CDC plan to make?
The CDC planned to make two awards under this opportunity.
What is the estimated total funding amount for this opportunity?
The estimated total funding amount is $3,000,000.
What is the maximum (ceiling) amount per award?
The award ceiling is $1,500,000, which aligns with the plan to make two awards that could be funded up to that amount each.
Is there a cost-sharing or matching requirement?
No. The announcement states there is no cost sharing or matching requirement.
What type of funding instrument is used?
The funding instrument is a cooperative agreement.
What does a cooperative agreement imply for how the project is carried out?
A cooperative agreement generally implies substantial involvement by the CDC during the project period, such as technical assistance, guidance on methodology, and coordination to support consistency and comparability across study sites.
Who is eligible to apply?
Eligible applicants include state and local government health departments serving populations of 1 million or more, as well as their bona fide agents.
Which U.S. territories and affiliated jurisdictions are explicitly included in eligibility?
The eligibility language explicitly includes the District of Columbia, Puerto Rico, the U.S. Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.
What is a "bona fide agent" in this announcement?
The announcement allows a bona fide agent to apply instead of the government health department itself, as long as the agent is recognized by the relevant state or local government for this purpose.
Is documentation required if applying as a bona fide agent?
Yes. If an entity applies as a bona fide agent, it must provide a letter from the relevant state or local government documenting that status.
When was the opportunity posted, and what was the application deadline?
The opportunity was posted on April 1, 2010, and the application deadline was May 10, 2010.
Is this funding opportunity still active?
No. The announcement was later archived on June 9, 2010.
What is the CFDA number for this program?
The CFDA number associated with the program is 93.283.
What CDC program category is this opportunity associated with?
It falls under the Centers for Disease Control and Prevention category of investigations and technical assistance, reflecting surveillance and epidemiologic research rather than direct clinical service delivery.
How does this opportunity relate to broader public health strategy?
The work is positioned as a continuation of the National Arthritis Action Plan: A Public Health Strategy (NAAP), with the intent to build the evidence base needed for better planning, awareness, and public health response to arthritis and related rheumatic diseases.
What specific work did the announcement call for?
The announcement calls for the implementation and completion of two additional population-based lupus studies.
Who can be contacted for help accessing the full announcement?
The listed point of contact is the CDC Procurement and Grants Office.
What are the contact details for the CDC Procurement and Grants Office for this opportunity?
Phone: 770-488-2700. Email: pgotim@cdc.gov.
Browse more opportunities from the same category: Health
Next opportunity: National Environmental Education Training Program
Previous opportunity: Evaluation of the Bureau of Justice Assistance Second Chance Act Adult Demonstration Projects
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DP10 1011
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DP10 1011) also looked into and applied for these:
| Funding Opportunity |
|---|
| Service Area Competition Additional Areas (SAC AA) Apply for HRSA 10 204 Funding Number: HRSA 10 204 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| FY 2010 Special Diabetes Program for Indians Community Directed Grant Program Apply for HHS 2010 IHS SDPI 0004 Funding Number: HHS 2010 IHS SDPI 0004 Agency: Indian Health Service Category: Health Funding Amount: $6,000,000 |
| State Based Oral Disease Prevention Program Apply for CDC RFA DP10 1012 Funding Number: CDC RFA DP10 1012 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Consortia for AIDS Vaccine Research in Nonhuman Primates (P01) Apply for RFA AI 10 004 Funding Number: RFA AI 10 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| FY10 Teenage Pregnancy Prevention Replication of Evidence based Programs (Tier 1) Apply for AH TP1 10 002 Funding Number: AH TP1 10 002 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $4,000,000 |
| Fogarty International Collaborative Trauma and Injury Research Training Program (TRAUMA) (D43) Apply for RFA TW 09 002 Funding Number: RFA TW 09 002 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Dental Reimbursement Program Apply for HRSA 10 083 Funding Number: HRSA 10 083 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Creutzfeldt Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation Apply for CDC RFA CK10 1001 Funding Number: CDC RFA CK10 1001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $65,000 |
| Non Communicable Disease Prevention and Health Promotion Apply for CDC RFA DP10 1010 Funding Number: CDC RFA DP10 1010 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Preliminary Clinical Studies in Preparation for Large Interventional Trials of Complementary and Alternative Medicine (CAM) Therapies (R34) Apply for PAR 10 163 Funding Number: PAR 10 163 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| National Center for Chronic Disease Prevention and Health Promotion, Division of Oral Health Apply for CDC RFA DP10 1018E Funding Number: CDC RFA DP10 1018E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| National Charcot Marie Tooth Resource Center Apply for CDC RFA DD10 1014 Funding Number: CDC RFA DD10 1014 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $800,000 |
| Tanzania Capacity and Communications Project (TCCP) Apply for USAID TANZANIA 10 006 RFA Funding Number: USAID TANZANIA 10 006 RFA Agency: Tanzania USAID Dar es Salaam Category: Health Funding Amount: $45,000,000 |
| Teenage Pregnancy Prevention Research and Demonstration Programs (Tier 2) and Personal Responsibility Education Program Apply for AH TP2 10 001 Funding Number: AH TP2 10 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,000,000 |
| Planning Grants for Pivotal Clinical Trials in Hemoglobinopathies (R34) Apply for RFA HL 11 009 Funding Number: RFA HL 11 009 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Effective Strategies to Reduce Motor Vehicle Injuries Among American Indians/Alaska Natives Apply for CDC RFA CE10 1001 Funding Number: CDC RFA CE10 1001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $70,000 |
| Integrating HIV Care and Treatment within the Network of Facilities Offering TB Treatment and Providing Technical Assistance to the Ministry of Health Toward Strengthening the National TB/HIV System in Haiti Under the President s Emergency Plan for A Apply for CDC RFA PS10 1011 Funding Number: CDC RFA PS10 1011 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Health Careers Opportunity Program Apply for HRSA 10 119 Funding Number: HRSA 10 119 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Cooperative Agreements for the National Suicide Prevention Lifeline Crisis Center Follow Up Apply for SM 10 014 Funding Number: SM 10 014 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $60,000 |
| The NEI Mentored Clinical Scientist Development Program Award (K12) Apply for PAR 10 166 Funding Number: PAR 10 166 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DP10 1011", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.